SSA
OFIX icon

Schonfeld Strategic Advisors’s Orthofix Medical OFIX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,687
Closed -$141K – 2463
2025
Q2 		$141K Buy
+12,687
New +$157K ﹤0.01% 1818
2024
Q1 		– Sell
-23,287
Closed -$314K – 2295
2023
Q4 		$314K Buy
+23,287
New +$274K ﹤0.01% 1420
2019
Q4 		– Sell
-66,700
Closed -$3.54M – 1427
2019
Q3 		$3.54M Buy
66,700
+49,600
+290% +$2.56M 0.1% 212
2019
Q2 		$905K Sell
17,100
-400
-2% -$21.3K 0.03% 474
2019
Q1 		$987K Sell
17,500
-621
-3% -$34.9K 0.03% 504
2018
Q4 		$951K Sell
18,121
-1,879
-9% -$107K 0.04% 490
2018
Q3 		$1.16M Buy
20,000
+421
+2% +$23.6K 0.05% 404
2018
Q2 		$1.11M Buy
+19,579
New +$1.11M 0.06% 378

Other funds holding OFIX

ECM
Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Schonfeld Strategic Advisors's OFIX Position: Q3 2025 in Review

Schonfeld Strategic Advisors sold out of Orthofix Medical (OFIX) in Q3 2025, closing a stake of 12,687 shares — an estimated $141K sold.

Schonfeld Strategic Advisors first reported a position in OFIX in Q2 2018 and held it in 8 quarters. The position peaked at $3.54M in Q3 2019. 145 funds tracked by Wall St. Rank hold OFIX as of Q3 2025.

  • Schonfeld Strategic Advisors reported no remaining Orthofix Medical position as of Q3 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 12,687 Orthofix Medical shares in Q3 2025, an estimated $141K.
  • Schonfeld Strategic Advisors first reported a position in Orthofix Medical in Q2 2018 and held it in 8 quarters.
  • Schonfeld Strategic Advisors's Orthofix Medical position peaked at $3.54M in Q3 2019.
  • 145 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.